Gerco den Hartog

3.5k total citations
61 papers, 1.0k citations indexed

About

Gerco den Hartog is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Gerco den Hartog has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 18 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Gerco den Hartog's work include SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (13 papers) and Respiratory viral infections research (10 papers). Gerco den Hartog is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (13 papers) and Respiratory viral infections research (10 papers). Gerco den Hartog collaborates with scholars based in Netherlands, United States and Japan. Gerco den Hartog's co-authors include Sheila E. Crowe, Lindsay D. Butcher, Peter B. Ernst, Fiona van der Klis, Huub F. J. Savelkoul, Rutger M. Schepp, R. J. Joost van Neerven, A. Lammers, H.K. Parmentier and Guy A. M. Berbers and has published in prestigious journals such as Nature Communications, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Gerco den Hartog

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerco den Hartog Netherlands 17 387 246 219 171 140 61 1.0k
Hongmei Xu China 20 338 0.9× 170 0.7× 272 1.2× 101 0.6× 496 3.5× 85 1.3k
Allison L. Totura United States 11 1.0k 2.6× 320 1.3× 222 1.0× 26 0.2× 143 1.0× 12 1.3k
Johannes P. C. van den Akker Netherlands 11 911 2.4× 202 0.8× 167 0.8× 26 0.2× 85 0.6× 19 1.2k
Xiang Huo China 18 273 0.7× 76 0.3× 246 1.1× 29 0.2× 280 2.0× 59 1.0k
Yu‐Ching Lan Taiwan 18 308 0.8× 229 0.9× 220 1.0× 110 0.6× 269 1.9× 62 1.1k
Mohammad A. I. Al-Hatamleh Malaysia 14 337 0.9× 65 0.3× 166 0.8× 47 0.3× 99 0.7× 38 922
Ka‐Wai Cheung Hong Kong 11 535 1.4× 161 0.7× 140 0.6× 22 0.1× 90 0.6× 18 939
Jian Tang China 13 711 1.8× 222 0.9× 310 1.4× 50 0.3× 197 1.4× 30 1.3k
Kyung Mok Sohn South Korea 14 678 1.8× 103 0.4× 191 0.9× 67 0.4× 289 2.1× 39 1.1k

Countries citing papers authored by Gerco den Hartog

Since Specialization
Citations

This map shows the geographic impact of Gerco den Hartog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerco den Hartog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerco den Hartog more than expected).

Fields of papers citing papers by Gerco den Hartog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerco den Hartog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerco den Hartog. The network helps show where Gerco den Hartog may publish in the future.

Co-authorship network of co-authors of Gerco den Hartog

This figure shows the co-authorship network connecting the top 25 collaborators of Gerco den Hartog. A scholar is included among the top collaborators of Gerco den Hartog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerco den Hartog. Gerco den Hartog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vos, Eric R. A., Stijn P. Andeweg, Gerco den Hartog, et al.. (2025). Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection. Epidemiology and Infection. 153. e38–e38. 1 indexed citations
2.
Woudenbergh, Esther van, Niels van Heerbeek, Jimmie Honings, et al.. (2025). Primary human nasal, nasopharyngeal, and bronchial epithelia show distinct immune responses to various pathogens. Pathogens and Disease. 83.
3.
Backer, Jantien A., Eric R. A. Vos, Gerco den Hartog, et al.. (2024). Contact behaviour before, during and after the COVID-19 pandemic in the Netherlands: evidence from contact surveys, 2016 to 2017 and 2020 to 2023. Eurosurveillance. 29(43). 3 indexed citations
4.
Nicolaie, Mioara Alina, Jolanda Brummelman, Martijn D. B. van de Garde, et al.. (2024). Serological Profiling of Pneumococcal Proteins Reveals Unique Patterns of Acquisition, Maintenance, and Waning of Antibodies Throughout Life. The Journal of Infectious Diseases. 230(6). e1299–e1310. 2 indexed citations
5.
Kooijman, Marjolein N., Hester E. de Melker, Susan Hahné, et al.. (2024). Cohort profile: an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands – the VAccine Study COVID-19 (VASCO). BMJ Open. 14(10). e085388–e085388. 5 indexed citations
6.
Vos, Eric R. A., Gaby Smits, Marjan Kuijer, et al.. (2024). SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response. Influenza and Other Respiratory Viruses. 18(6). e13312–e13312. 4 indexed citations
7.
8.
Maas, Nicoline van der, Mireille N. Bekker, Hester E. de Melker, et al.. (2024). Decay Rates of Maternal Tetanus, Diphtheria, and Pertussis Antibody Levels in Early and Moderate-to-Late Preterm and Term Infants at Birth and at Two Months. Open Forum Infectious Diseases. 12(1). ofae717–ofae717.
9.
10.
Boer, Pieter T. de, Jan van de Kassteele, Eric R. A. Vos, et al.. (2023). Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands. Influenza and Other Respiratory Viruses. 17(8). e13174–e13174. 7 indexed citations
11.
Woudenbergh, Esther van, Mioara Alina Nicolaie, Martijn A. Huynen, et al.. (2023). Effect of age and season on respiratory mucosal immune marker profiles. Journal of Allergy and Clinical Immunology. 153(6). 1681–1691.e12. 1 indexed citations
12.
Gier, Brechje de, Gerco den Hartog, Cornelis H. van Werkhoven, et al.. (2023). Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology. Nature Communications. 14(1). 4793–4793. 19 indexed citations
13.
Prins, Margaretha, Rob van Binnendijk, Gerco den Hartog, et al.. (2022). Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study. Annals of Internal Medicine. 175(12). 1771–1774. 15 indexed citations
14.
Vos, Eric R. A., Michiel van Boven, Gerco den Hartog, et al.. (2021). Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands. Clinical Infectious Diseases. 73(12). 2318–2321. 25 indexed citations
15.
Vos, Eric R. A., Jeffrey van Vliet, Gerco den Hartog, et al.. (2021). Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study. International Journal of Infectious Diseases. 111. 21–27. 1 indexed citations
16.
Varghese, Finny S., Esther van Woudenbergh, Gijs J. Overheul, et al.. (2021). Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro. Viruses. 13(2). 282–282. 52 indexed citations
17.
Pino, Paco, Joeri Kint, Divor Kiseljak, et al.. (2020). Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens. Processes. 8(12). 1539–1539. 11 indexed citations
18.
Hartog, Gerco den, Rutger M. Schepp, Marjan Kuijer, et al.. (2020). SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence. The Journal of Infectious Diseases. 222(9). 1452–1461. 80 indexed citations
19.
Butcher, Lindsay D., Gerco den Hartog, Amber Ablack, et al.. (2018). 149 - Gastrointestinal Microbes Enhance the Accumulation of Reactive Oxygen Species (ROS) and Dna Damage that are Regulated by Apurinic/Apyrimidinic Endonuclease 1 (APE1). Gastroenterology. 154(6). S–41. 1 indexed citations
20.
Hartog, Gerco den, R. J. Joost van Neerven, J. D. Boot, A.P. Jansen, & Huub F. J. Savelkoul. (2015). House dust mite-specific IgA2 is associated with protection against eczema in allergic patients. Allergy. 71(4). 563–566. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongmei Xu Breakdown of academic impact, for papers by Allison L. Totura Breakdown of academic impact, for papers by Johannes P. C. van den Akker Breakdown of academic impact, for papers by Xiang Huo Breakdown of academic impact, for papers by Yu‐Ching Lan Breakdown of academic impact, for papers by Mohammad A. I. Al-Hatamleh Breakdown of academic impact, for papers by Ka‐Wai Cheung Breakdown of academic impact, for papers by Jian Tang Breakdown of academic impact, for papers by Kyung Mok Sohn
Rankless by CCL
2026